Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 20, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 80,312 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on November 16, 2006, and was advised to the Company on November 17, 2006.
Management Commentary and Risks
The GSK Trust is identified as a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Three directors—Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop—are noted as having an interest in the shares held in the GSK Trust in the same capacity as other employees. The filing contains no specific guidance, outlook, or discussion of risks beyond the standard disclosure of the share transaction.
Key Facts for Investor Verification
- Transaction Date: November 16, 2006.
- Shares Transferred: 80,312 Ordinary Shares.
- Source: GlaxoSmithKline Employee Trust (GSK Trust).
- Beneficiaries: Participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Directors Involved: Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop (as interested parties in the trust).